Skip to main content
Blood Advances logoLink to Blood Advances
. 2022 Mar 3;6(5):1536. doi: 10.1182/bloodadvances.2021005395

Weisdorf D, Cooley S, Wang T, et al. KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation. Blood Adv. 2020;4(4):740-754.

PMCID: PMC8905686  PMID: 35238913

In “Acknowledgments” on page 753, National Cancer Institute (NCI) grant U24CA233032-01 should not have been cited. The error has been corrected in the published article.


Articles from Blood Advances are provided here courtesy of The American Society of Hematology

RESOURCES